Skip to main content
Premium Trial:

Request an Annual Quote

Doug Fisher, Arnold Oronsky

Doug Fisher has joined Sera Prognostics as chief business officer. The company also has appointed Arnold Oronsky to its board. Fisher has been a partner at venture capital firm InterWest Partners and served on Sera's board starting in late 2011. Sera said that he has resigned as a director in connection to his joining the company's management team. 

Oronsky is a general partner at InterWest and has investment experience in diagnostics and pharmaceutical companies, Sera said. Before joining InterWest, he was vice president of discovery research at Lederle Laboratories, a division of American Cyanamid.